|
1
|
Hoeper MM, Humbert M, Souza R, Idrees M,
Kawut SM, Sliwa-Hahnle K, Jing ZC and Gibbs JS: A global view of
pulmonary hypertension. Lancet Respir Med. 4:306–322.
2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Raza T and Dilawar M: Pulmonary
hypertension: A comprehensive review. Heart Views. 8:90–99.
2007.
|
|
3
|
McGoon MD and Miller DP: REVEAL: A
contemporary US pulmonary arterial hypertension registry. Eur
Respir Rev. 21:8–18. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Athanasiou KA, Sahni S, Rana A and Talwar
A: Diagnosing and managing scleroderma-related pulmonary arterial
hypertension. JAAPA. 30:11–18. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shirai Y, Yasuoka H, Okano Y, Takeuchi T,
Satoh T and Kuwana M: Clinical characteristics and survival of
Japanese patients with connective tissue disease and pulmonary
arterial hypertension: A single-centre cohort. Rheumatology
(Oxford). 51:1846–1854. 2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kang KY, Jeon CH, Choi SJ, Yoon BY, Choi
CB, Lee CH, Suh CH, Lee CW, Cho CS, Nam EJ, et al: Survival and
prognostic factors in patients with connective tissue
disease-associated pulmonary hypertension diagnosed by
echocardiography: Results from a Korean nationwide registry. Int J
Rheum Dis. 20:1227–1236. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jing ZC, Xu XQ, Han ZY, Wu Y, Deng KW,
Wang H, Wang ZW, Cheng XS, Xu B, Hu SS, et al: Registry and
survival study in Chinese patients with idiopathic and familial
pulmonary arterial hypertension. Chest. 132:373–379.
2007.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Li M, Wang Q, Zhao J, Li Z, Ye Z, Li C, Li
X, Zhu P, Wang Z, Zheng Y, et al: Chinese SLE treatment and
research group (CSTAR) registry: II. Prevalence and risk factors of
pulmonary arterial hypertension in Chinese patients with systemic
lupus erythematosus. Lupus. 23:1085–1091. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chen HA, Hsu TC, Yang SC, Weng CT, Wu CH,
Sun CY and Lin CY: Incidence and survival impact of pulmonary
arterial hypertension among patients with systemic lupus
erythematosus: A nationwide cohort study. Arthritis Res Ther.
21(82)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Jankov RP, Luo X, Cabacungan J, Belcastro
R, Frndova H, Lye SJ and Tanswell AK: Endothelin-1 and O2-mediated
pulmonary hypertension in neonatal rats: A role for products of
lipid peroxidation. Pediatr Res. 48:289–298. 2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kopeć G, Waligóra M, Tyrka A, Jonas K,
Pencina MJ, Zdrojewski T, Moertl D, Stokwiszewski J, Zagożdżon P
and Podolec P: Low-density lipoprotein cholesterol and survival in
pulmonary arterial hypertension. Sci Rep. 7(41650)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Al-Naamani N, Palevsky HI, Lederer DJ,
Horn EM, Mathai SC, Roberts KE, Tracy RP, Hassoun PM, Girgis RE,
Shimbo D, et al: Prognostic significance of biomarkers in pulmonary
arterial hypertension. Ann Am Thorac Soc. 13:25–30. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang GF, Guan LH, Zhou DX, Chen DD, Zhang
XC and Ge JB: Serum high-density lipoprotein cholesterol is
significantly associated with the presence and severity of
pulmonary arterial hypertension: A retrospective cross-sectional
study. Adv Ther. 37:2199–2209. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Jonas K, Magoń W, Waligóra M, Seweryn M,
Podolec P and Kopeć G: High-density lipoprotein cholesterol levels
and pulmonary artery vasoreactivity in patients with idiopathic
pulmonary arterial hypertension. Pol Arch Intern Med. 128:440–446.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pašková U: Lipid profile and risks of
cardiovascular diseases in conditions of rheumatoid arthritis.
Ceska Slov Farm. 68:219–228. 2019.PubMed/NCBI
|
|
16
|
Kato F, Tanabe N, Urushibara T, Kasai H,
Takeuchi T, Sekine A, Suda R, Nishimura R, Jujo T, Sugiura T, et
al: Association of plasma fibrinogen and plasminogen with prognosis
of inoperable chronic thromboembolic pulmonary hypertension. Circ
J. 78:1754–1761. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Shitrit D, Bendayan D, Rudensky B, Izbicki
G, Huerta M, Fink G and Kramer MR: Elevation of ELISA D-dimer
levels in patients with primary pulmonary hypertension.
Respiration. 69:327–329. 2002.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kiatchoosakun S, Ungkasekvinai W,
Wonvipaporn C, Tatsanavivat P, Foocharoen C, Suwannaroj S and
Nanagara R: D-dimer and pulmonary arterial hypertension in systemic
sclerosis. J Med Assoc Thai. 90:2024–2029. 2007.PubMed/NCBI
|
|
19
|
Tracy RP: Diet and hemostatic factors.
Curr Atheroscler Rep. 1:243–248. 1999.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Hochberg MC: Updating the American college
of rheumatology revised criteria for the classification of systemic
lupus erythematosus. Arthritis Rheum. 40(1725)1997.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Pyxaras SA, Pinamonti B, Barbati G,
Santangelo S, Valentincic M, Cettolo F, Secoli G, Magnani S, Merlo
M, Lo Giudice F, et al: Echocardiographic evaluation of systolic
and mean pulmonary artery pressure in the follow-up of patients
with pulmonary hypertension. Eur J Echocardiogr. 12:696–701.
2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Crouse WL, Keele GR, Gastonguay MS,
Churchill GA and Valdar W: A bayesian model selection approach to
mediation analysis. PLoS Genet. 18(e1010184)2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Baron RM and Kenny DA: The
moderator-mediator variable distinction in social psychological
research: Conceptual, strategic, and statistical considerations. J
Pers Soc Psychol. 51:1173–1182. 1986.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shrout PE and Bolger N: Mediation in
experimental and nonexperimental studies: New procedures and
recommendations. Psychol Methods. 7:422–445. 2002.PubMed/NCBI
|
|
25
|
Guo X, Lai J, Wang H, Tian Z, Wang Q, Zhao
J, Li M, Fang Q, Fang L, Liu Y and Zeng X: Predictive value of
non-invasive right ventricle to pulmonary circulation coupling in
systemic lupus erythematosus patients with pulmonary arterial
hypertension. Eur Heart J Cardiovasc Imaging. 22:111–118.
2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Qu J, Li M, Wang Y, Duan X, Luo H, Zhao C,
Zhan F, Wu Z, Li H, Yang M, et al: Predicting the risk of pulmonary
arterial hypertension in systemic lupus erythematosus: A chinese
systemic lupus erythematosus treatment and research group cohort
study. Arthritis Rheumatol. 73:1847–1855. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Johnson SR, Gladman DD, Urowitz MB, Ibanez
D and Granton JT: Pulmonary hypertension in systemic lupus. Lupus.
13:506–509. 2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kiani R, Siddiqui MD and Tantoush H:
Severe pulmonary hypertension as initial presentation of SLE: A
case report and literature review. Case Rep Rheumatol.
2020(6014572)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lian F, Chen D, Wang Y, Ye Y, Wang X, Zhan
Z, Xu H, Liang L and Yang X: Clinical features and independent
predictors of pulmonary arterial hypertension in systemic lupus
erythematosus. Rheumatol Int. 32:1727–1731. 2012.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chung L, Liu J, Parsons L, Hassoun PM,
McGoon M, Badesch DB, Miller DP, Nicolls MR and Zamanian RT:
Characterization of connective tissue disease-associated pulmonary
arterial hypertension from REVEAL: Identifying systemic sclerosis
as a unique phenotype. Chest. 138:1383–1394. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Liu X, Zhou F, Yang Y, Wang W, Niu L, Zuo
D, Li X, Hua H, Zhang B, Kou Y, et al: MiR-409-3p and MiR-1896
co-operatively participate in IL-17-induced inflammatory cytokine
production in astrocytes and pathogenesis of EAE mice via targeting
SOCS3/STAT3 signaling. Glia. 67:101–112. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ferreira KS, Cicarini WB, Alves LCV,
Loures CMG, Campos FMF, Santos LID, da Silva MVF, Guimarães TMD,
Toledo VPCP, Reis EA, et al: Correlation between active disease and
hypercoagulability state in patients with systemic lupus
erythematosus. Clin Chim Acta. 490:107–112. 2019.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
33
|
Xu SZ, Liang Y, Li XP, Li XM, Shuai ZW,
Leng RX, Pan HF and Ye DQ: Features associated with pulmonary
arterial hypertension in Chinese hospitalized systemic lupus
erythematosus patients. Clin Rheumatol. 37:1547–1553.
2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wang Y, Yu H and He J: Role of
dyslipidemia in accelerating inflammation, autoimmunity, and
atherosclerosis in systemic lupus erythematosus and other
autoimmune diseases. Discov Med. 30:49–56. 2020.PubMed/NCBI
|
|
35
|
Robinson G, Pineda-Torra I, Ciurtin C and
Jury EC: Lipid metabolism in autoimmune rheumatic disease:
Implications for modern and conventional therapies. J Clin Invest.
132(e148552)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhou B, Xia Y and She J: Dysregulated
serum lipid profile and its correlation to disease activity in
young female adults diagnosed with systemic lupus erythematosus: A
cross-sectional study. Lipids Health Dis. 19(40)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Heresi GA, Aytekin M, Newman J, DiDonato J
and Dweik RA: Plasma levels of high-density lipoprotein cholesterol
and outcomes in pulmonary arterial hypertension. Am J Respir Crit
Care Med. 182:661–668. 2010.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhao QH, Peng FH, Wei H, He J, Chen FD, Di
RM, Jiang X, Jiang R, Chen YJ, Heresi GA and Jing ZC: Serum
high-density lipoprotein cholesterol levels as a prognostic
indicator in patients with idiopathic pulmonary arterial
hypertension. Am J Cardiol. 110:433–439. 2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Chen J, Rathinasabapathy A, Luo J, Yang X,
Luo P, Chen Y, Li Z and Li J: Differential serum lipid distribution
in IPAH and CHD-PAH patients. Respir Med.
191(106711)2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Choy E and Sattar N: Interpreting lipid
levels in the context of high-grade inflammatory states with a
focus on rheumatoid arthritis: A challenge to conventional
cardiovascular risk actions. Ann Rheum Dis. 68:460–469.
2009.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Alexopoulos CG, Pournaras S, Vaslamatzis
M, Avgerinos A and Raptis S: Changes in serum lipids and
lipoproteins in cancer patients during chemotherapy. Cancer
Chemother Pharmacol. 30:412–416. 1992.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Peev V, Nayer A and Contreras G:
Dyslipidemia, malnutrition, inflammation, cardiovascular disease
and mortality in chronic kidney disease. Curr Opin Lipidol.
25:54–60. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Gombos T, Förhécz Z, Pozsonyi Z, Jánoskuti
L, Prohászka Z and Karádi I: Long-term survival and apolipoprotein
A1 level in chronic heart failure: Interaction with tumor necrosis
factor α-308 G/A polymorphism. J Card Fail. 23:113–120.
2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Liu Y, Coresh J, Eustace JA, Longenecker
JC, Jaar B, Fink NE, Tracy RP, Powe NR and Klag MJ: Association
between cholesterol level and mortality in dialysis patients: Role
of inflammation and malnutrition. JAMA. 291:451–459.
2004.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Araújo JP, Friões F, Azevedo A, Lourenço
P, Rocha-Gonçalves F, Ferreira A and Bettencourt P: Cholesterol-a
marker of nutritional status in mild to moderate heart failure. Int
J Cardiol. 129:65–68. 2008.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Møller S and Bernardi M: Interactions of
the heart and the liver. Eur Heart J. 34:2804–2811. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Umar S, Ruffenach G, Moazeni S,
Vaillancourt M, Hong J, Cunningham C, Cao N, Navab S, Sarji S, Li
M, et al: Involvement of low-density lipoprotein receptor in the
pathogenesis of pulmonary hypertension. J Am Heart Assoc.
9(e012063)2020.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Tehrani DM, Grinstein J, Kalantari S, Kim
G, Sarswat N, Adatya S, Sayer G and Uriel N: Cardiac output
assessment in patients supported with left ventricular assist
device: Discordance between thermodilution and indirect fick
cardiac output measurements. ASAIO J. 63:433–437. 2017.PubMed/NCBI View Article : Google Scholar
|
